
AdvaMed®’s Medical Innovation Agenda for the 119th Congress
AdvaMed®’s medtech priorities for the 119th Congress highlight opportunities to address the most important issues facing patients and the medical technology industry today.
Learn more about our Advocacy work.

AdvaMed®’s medtech priorities for the 119th Congress highlight opportunities to address the most important issues facing patients and the medical technology industry today.

Get expert insights, key documents, and event details on trade and policy shifts.
Washington, D.C.– AdvaMed, The Medtech Association®, today released the following statement from President and CEO Scott Whitaker on the U.S. Senate’s confirmation of Dr. Marty Makary to serve as commissioner of…

Discover how AI is transforming medical technology with the AI Policy Roadmap. Learn how Congress can unleash even more innovation with targeted legislation. Download your copy today!

AdvaMed®’s medtech priorities for the 119th Congress highlight opportunities to address the most important issues facing patients and the medical technology industry today.
Hear from Multistate policy experts Joe Rinzel and Townsend Brown as they discuss state product stewardship and producer responsibility policy trends.

Tariffs on medical goods threaten healthcare costs, access, and supply chains. Leading health groups urge exemptions to safeguard patient care.
Hear from expert speakers as they give an overview of PFAS and emerging PFAS policy trends across the country.

An overview of the Make America Healthy Again Commission, its mission to address chronic disease in the U.S., and policy initiatives aimed at improving public health.

A breakdown of the administration’s trade policy, highlighting key areas where the U.S. seeks to level the playing field with trading partners through reciprocal tariffs.